| LP418196-4 | Interferon-gamma producing HLA-B8 Cytomegalovirus specific CD8 cells | COMPONENT | 1 |
| LP418197-2 | Interferon-gamma producing HLA-B35 Cytomegalovirus specific CD8 cells | COMPONENT | 1 |
| LP418198-0 | Interferon-gamma producing Cytomegalovirus-specific CD8 cells | COMPONENT | 1 |
| LP418199-8 | CD107a+b expressing HLA-A1 Cytomegalovirus specific CD8 cells | COMPONENT | 1 |
| LP418200-4 | CD107a+b expressing HLA-A2 Cytomegalovirus specific CD8 cells | COMPONENT | 1 |
| LP418201-2 | CD107a+b expressing HLA-B7 Cytomegalovirus specific CD8 cells | COMPONENT | 1 |
| LP418202-0 | CD107a+b expressing HLA-B8 Cytomegalovirus specific CD8 cells | COMPONENT | 1 |
| LP418203-8 | CD107a+b expressing HLA-B35 Cytomegalovirus specific CD8 cells | COMPONENT | 1 |
| LP418204-6 | CD107a+b expressing Cytomegalovirus-specific CD8 cells | COMPONENT | 1 |
| LP418207-9 | PMA+ionomycin stimulated gamma interferon producing CD8 Cells | COMPONENT | |
| LP418208-7 | PMA+ionomycin stimulated CD107a+b expressing CD8 cells | COMPONENT | |
| LP418209-5 | Cytomegalovirus-specific CD8 cells | COMPONENT | 1 |
| LP418210-3 | Catecholamines supine and standing panel | COMPONENT | 1 |
| LP418221-0 | Chromosome region 14q32 rearrangements | COMPONENT | 1 |
| LP418222-8 | Chromosome 9 and 11 and 15 aneuploidy | COMPONENT | 1 |
| LP418223-6 | Chromosome 1q and 9 and 11 and 15 aneuploidy and 13q deletion | COMPONENT | 1 |
| LP418224-4 | EPINEPHrine^standing | COMPONENT | 1 |
| LP418225-1 | DOPamine^supine | COMPONENT | 1 |
| LP418226-9 | DOPamine^standing | COMPONENT | 1 |
| LP418229-3 | Tetrahydrocannabinol | DIVISORS | |
| LP418230-1 | Chromosome 1q and 9 and 11 and 15 aneuploidy and 13q | COMPONENT | |
| LP418231-9 | Hepatitis B virus surface Ag and Hepatitis B virus e Ab and Ag panel | COMPONENT | 1 |
| LP418235-0 | UGT1A1 gene TA repeats | COMPONENT | 1 |
| LP418236-8 | Disease stage | COMPONENT | 1 |
| LP418237-6 | Disease stage classification method | COMPONENT | 1 |
| LP418238-4 | Hepatitis D virus Ab panel | COMPONENT | 1 |
| LP418240-0 | COVID-19 Consultation note | COMPONENT | 2 |
| LP418244-2 | Coagulation factor VIII activity and inhibitor panel | COMPONENT | 2 |
| LP418245-9 | Require help from others | COMPONENT | 1 |
| LP418252-5 | Refused specimen collection | COMPONENT | 1 |
| LP418254-1 | RHCE gene allele | COMPONENT | 1 |
| LP418255-8 | Aldosterone and sodium panel | COMPONENT | 1 |
| LP418256-6 | corrected for glycerol | ADJUSTMENT | |
| LP418257-4 | Functional assessment standardized items (FASI) - version 1.0 | COMPONENT | 1 |
| LP418258-2 | FASI v1.0 - Self-care - usual performance | COMPONENT | 1 |
| LP418259-0 | FASI v1.0 - Self-care - most dependent performance | COMPONENT | 1 |
| LP418260-8 | FASI v1.0 - Mobility - usual performance | COMPONENT | 1 |
| LP418261-6 | FASI v1.0 - Mobility - most dependent performance | COMPONENT | 1 |
| LP418262-4 | Eating - most dependent performance during the past month | COMPONENT | 1 |
| LP418263-2 | Oral hygiene - most dependent performance during the past month | COMPONENT | 1 |
| LP418264-0 | Wash upper body - most dependent performance during the past month | COMPONENT | 1 |
| LP418265-7 | Shower/bathe self - most dependent performance during the past month | COMPONENT | 1 |
| LP418266-5 | Upper body dressing - most dependent performance during the past month | COMPONENT | 1 |
| LP418267-3 | Lower body dressing - most dependent performance during the past month | COMPONENT | 1 |
| LP418268-1 | Putting on and taking off footwear - most dependent performance during the past month | COMPONENT | 1 |
| LP418269-9 | Self-care priorities for the next 6 months | COMPONENT | 1 |
| LP418270-7 | Roll left and right - most dependent performance during the past month | COMPONENT | 1 |
| LP418271-5 | Sit to lying - most dependent performance during the past month | COMPONENT | 1 |
| LP418272-3 | Lying to sitting on side of bed - most dependent performance during the past month | COMPONENT | 1 |
| LP418273-1 | Sit to stand - most dependent performance during the past month | COMPONENT | 1 |